HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 48186,
"recordsTotal": 48186,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=-status&start=47400",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=-status&start=46800",
"results": [
{
"registry_id": "NCT07303946",
"publication_url": "https://clinicaltrials.gov/study/NCT07303946",
"title": "Double-Blind, Crossover, Feasibility Study of Deep Brain Stimulation of the Anterior Cingulate Bundle (ACB) and the Ventral Anterior Limb of the Internal Capsule (vALIC) in Patients With Intractable Obsessive Compulsive Disorder (OCD)",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rhode Island Hospital",
"sponsor_slug": "rhode-island-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07280468",
"publication_url": "https://clinicaltrials.gov/study/NCT07280468",
"title": "Endotype DIrected Treatment for OSA in Down Syndrome",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07332442",
"publication_url": "https://clinicaltrials.gov/study/NCT07332442",
"title": "Continuous Positive Airway Pressure, Arousability and Links to Mechanisms in Obstructive Sleep Apnea",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07369115",
"publication_url": "https://clinicaltrials.gov/study/NCT07369115",
"title": "Intra-Cellular Therapies, Inc. / \"A Randomized, Double-blind, Placebo-controlled, Single Site Study to Evaluate the Efficacy of Lumateperone for the Treatment of Major Depressive Disorder (MDD) and Early Life Trauma in Adult Patients Aged 21 to 70 Years",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07142343",
"publication_url": "https://clinicaltrials.gov/study/NCT07142343",
"title": "An Open-Label, Single-Arm Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Pozelimab in Pediatric Patients 1 to 5 Years of Age With CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease)",
"has_exemption": false,
"start_date": "2026-03-06",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07328503",
"publication_url": "https://clinicaltrials.gov/study/NCT07328503",
"title": "A Phase II Study to Examine the Impact of CD22 CAR T-cells to Extend the Duration of Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2026-03-24",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07050862",
"publication_url": "https://clinicaltrials.gov/study/NCT07050862",
"title": "Circuity-guided Repetitive Transcranial Magnetic Stimulation (rTMS) for Tobacco Use in Veterans: A Comparison of Insula-rTMS and Prefrontal-rTMS",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07010302",
"publication_url": "https://clinicaltrials.gov/study/NCT07010302",
"title": "A Comparative Clinical Effectiveness Trial of Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab and Eculizumab To Prevent Relapses in Neuromyelitis Optica Spectrum Disorder",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07264920",
"publication_url": "https://clinicaltrials.gov/study/NCT07264920",
"title": "Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07419425",
"publication_url": "https://clinicaltrials.gov/study/NCT07419425",
"title": "Comparing Three Multicomponent Interventions to Help Adults Quit Smoking",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07069699",
"publication_url": "https://clinicaltrials.gov/study/NCT07069699",
"title": "Phase 1b/2 Trial of Pidnarulex in MYC Aberrant Lymphoma",
"has_exemption": false,
"start_date": "2026-10-13",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07470164",
"publication_url": "https://clinicaltrials.gov/study/NCT07470164",
"title": "A Randomized Trial of Botulinum Toxin A vs Strabismus Surgery for Esotropia >10 to ≤30PD",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jaeb Center for Health Research",
"sponsor_slug": "jaeb-center-for-health-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01754363",
"publication_url": "https://clinicaltrials.gov/study/NCT01754363",
"title": "Short, Medium and Long Term Survivorship of Attune Primary Knee Prosthesis",
"has_exemption": false,
"start_date": "2013-02-01",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "DePuy International",
"sponsor_slug": "depuy-international",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06853665",
"publication_url": "https://clinicaltrials.gov/study/NCT06853665",
"title": "A Pharmaco-Imaging Trial of Mixed Amphetamine Salts for the Treatment of ADHD in Intellectually-intact Youth With Autism Spectrum Disorder",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Gagan Joshi",
"sponsor_slug": "gagan-joshi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284641",
"publication_url": "https://clinicaltrials.gov/study/NCT07284641",
"title": "Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Paul Szabolcs",
"sponsor_slug": "paul-szabolcs",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07439510",
"publication_url": "https://clinicaltrials.gov/study/NCT07439510",
"title": "A Phase 2b/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SPG601 in Male Participants With Fragile X Syndrome",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Spinogenix",
"sponsor_slug": "spinogenix",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07313787",
"publication_url": "https://clinicaltrials.gov/study/NCT07313787",
"title": "Prospective Cross-Over Study of the Effects of Meal Macronutrients on Postprandial Lipids",
"has_exemption": false,
"start_date": "2026-03-24",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07061951",
"publication_url": "https://clinicaltrials.gov/study/NCT07061951",
"title": "A Phase 2 Pilot Study of Mirdametinib in Relapsed Refractory Chronic Lymphocytic Leukemia",
"has_exemption": false,
"start_date": "2026-09-08",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221357",
"publication_url": "https://clinicaltrials.gov/study/NCT07221357",
"title": "ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2030-02-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06413680",
"publication_url": "https://clinicaltrials.gov/study/NCT06413680",
"title": "A Phase 1/2a, Open-Label, Dose Escalation and Dose Expansion First-In-Human Study of the Safety, Tolerability, Activity, and Pharmacokinetics of REGN10597 (Anti-PD-1-IL-2RA-IL-2 Fusion Protein) Alone or in Combination With Cemiplimab in Patients With Advanced Solid Organ Malignancies",
"has_exemption": false,
"start_date": "2024-09-23",
"completion_date": "2030-02-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07401823",
"publication_url": "https://clinicaltrials.gov/study/NCT07401823",
"title": "An Open-Label Extension Study to Evaluate Long-Term Safety and Tolerability of Pociredir in Participants With Sickle Cell Disease (SCD) Who Have Participated in a Pociredir Study",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-02-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Fulcrum Therapeutics",
"sponsor_slug": "fulcrum-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03309332",
"publication_url": "https://clinicaltrials.gov/study/NCT03309332",
"title": "OSB Lead-AMPLATZER PFO Occluder New Enrollment PAS",
"has_exemption": false,
"start_date": "2018-01-31",
"completion_date": "2030-02-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Abbott Medical Devices",
"sponsor_slug": "abbott-medical-devices",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04528082",
"publication_url": "https://clinicaltrials.gov/study/NCT04528082",
"title": "A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study, Followed by an Active Treatment Phase to Evaluate the Efficacy and Safety of Apremilast in Children From 2 to Less Than 18 Years of Age With Active Oral Ulcers Associated With Behçet's Disease (BEAN)",
"has_exemption": false,
"start_date": "2021-09-09",
"completion_date": "2030-02-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04980872",
"publication_url": "https://clinicaltrials.gov/study/NCT04980872",
"title": "A Multicenter, Open-label, Phase 2, Extension Trial to Study the Long-term Safety in Participants With PROS or Proteus Syndrome Who Are Currently Being Treated With Miransertib in Other Studies",
"has_exemption": false,
"start_date": "2021-11-02",
"completion_date": "2030-02-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06799390",
"publication_url": "https://clinicaltrials.gov/study/NCT06799390",
"title": "Vagus Nerve Stimulation Following Intracerebral Hemorrhage (IHC) to Mitigate ICH-induced Inflammation and Cerebral Edema",
"has_exemption": false,
"start_date": "2025-04-06",
"completion_date": "2030-02-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07204249",
"publication_url": "https://clinicaltrials.gov/study/NCT07204249",
"title": "Glutide for Ending Methamphetamine",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2030-02-15",
"has_results": false,
"results_due": false,
"sponsor_name": "San Francisco Department of Public Health",
"sponsor_slug": "san-francisco-department-of-public-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06863272",
"publication_url": "https://clinicaltrials.gov/study/NCT06863272",
"title": "MK-2400-01A Substudy: A Phase 1/2, Open-label Umbrella Substudy of MK-2400-U01 Master Protocol to Evaluate the Safety and Efficacy of Ifinatamab Deruxtecan-based Treatment Combinations or Ifinatamab Deruxtecan Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (IDeate-Prostate02)",
"has_exemption": false,
"start_date": "2025-07-03",
"completion_date": "2030-02-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03813407",
"publication_url": "https://clinicaltrials.gov/study/NCT03813407",
"title": "An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia",
"has_exemption": false,
"start_date": "2019-04-02",
"completion_date": "2030-02-21",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07000149",
"publication_url": "https://clinicaltrials.gov/study/NCT07000149",
"title": "A Phase Ib/III Randomized, Multicenter, Global Study of Volrustomig Plus Casdatifan or Volrustomig Monotherapy Versus Nivolumab Plus Ipilimumab as First-line Treatment for Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2030-02-21",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04104776",
"publication_url": "https://clinicaltrials.gov/study/NCT04104776",
"title": "A Phase 1/2 Study of DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas",
"has_exemption": false,
"start_date": "2019-09-18",
"completion_date": "2030-02-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00338377",
"publication_url": "https://clinicaltrials.gov/study/NCT00338377",
"title": "Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma",
"has_exemption": false,
"start_date": "2006-02-01",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01966367",
"publication_url": "https://clinicaltrials.gov/study/NCT01966367",
"title": "CD34+ Stem Cell Selection for Patients Receiving a Matched or Partially Matched Family or Unrelated Adult Donor Allogeneic Stem Cell Transplantation for Non-Malignant Disease",
"has_exemption": false,
"start_date": "2013-03-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Diane George",
"sponsor_slug": "diane-george",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02912312",
"publication_url": "https://clinicaltrials.gov/study/NCT02912312",
"title": "Shortening Adjuvant Photon Irradiation to Reduce Edema (SAPHIRE): A Randomized Trial of Hypofractionated Versus Conventionally Fractionated Regional Nodal Irradiation for Invasive Breast Cancer",
"has_exemption": false,
"start_date": "2017-02-23",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03424850",
"publication_url": "https://clinicaltrials.gov/study/NCT03424850",
"title": "A Phase I/II Dose-escalation Study Evaluating the Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy",
"has_exemption": false,
"start_date": "2018-02-27",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03726554",
"publication_url": "https://clinicaltrials.gov/study/NCT03726554",
"title": "Comprehensive Reverse Shoulder: Porous Augmented Glenoid Baseplate and Mini Humeral Tray Post-Market Clinical Follow-up Study",
"has_exemption": false,
"start_date": "2018-08-28",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04408352",
"publication_url": "https://clinicaltrials.gov/study/NCT04408352",
"title": "Selective Bladder Denervation Using RF Energy for the Treatment of UUI",
"has_exemption": false,
"start_date": "2020-04-27",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Hologic, Inc.",
"sponsor_slug": "hologic-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06128564",
"publication_url": "https://clinicaltrials.gov/study/NCT06128564",
"title": "A Two-Part, Open-Label Systemic Gene Delivery Study to Evaluate the Safety and Expression of RO7494222 (SRP-9001) in Subjects Under the Age of Four With Duchenne Muscular Dystrophy",
"has_exemption": false,
"start_date": "2023-11-29",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06433635",
"publication_url": "https://clinicaltrials.gov/study/NCT06433635",
"title": "Sequential Multiple Assignment Randomized Trial for Bipolar Depression",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06895785",
"publication_url": "https://clinicaltrials.gov/study/NCT06895785",
"title": "Exalt Single-use Duodenoscope Vs Reusable Scope, a Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-02-21",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Rush University Medical Center",
"sponsor_slug": "rush-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06839976",
"publication_url": "https://clinicaltrials.gov/study/NCT06839976",
"title": "CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Adolescents and Young Adults With Systemic Lupus Erythematosus (SLE)",
"has_exemption": false,
"start_date": "2025-05-06",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Philadelphia",
"sponsor_slug": "childrens-hospital-of-philadelphia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06919666",
"publication_url": "https://clinicaltrials.gov/study/NCT06919666",
"title": "Phase Ib/II Study of NT219 in Combination With Pembrolizumab or Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07003997",
"publication_url": "https://clinicaltrials.gov/study/NCT07003997",
"title": "Janus Kinase (JAK) Signaling in Depression",
"has_exemption": false,
"start_date": "2025-09-03",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07278505",
"publication_url": "https://clinicaltrials.gov/study/NCT07278505",
"title": "Pathophysiological Mechanisms of Cannabidiol in Stress Regulation",
"has_exemption": false,
"start_date": "2025-10-28",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06890338",
"publication_url": "https://clinicaltrials.gov/study/NCT06890338",
"title": "A Single-Arm, Phase 2 Study of Neoadjuvant Carboplatin and Mirvetuximab Soravtansine in Subjects With FRα-Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer",
"has_exemption": false,
"start_date": "2025-11-21",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06686771",
"publication_url": "https://clinicaltrials.gov/study/NCT06686771",
"title": "Consolidative Use of Radiotherapy to Block (CURB2) Oligoprogression In Patients With Metastatic Non-Small-Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-12-16",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Canadian Cancer Trials Group",
"sponsor_slug": "canadian-cancer-trials-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07278557",
"publication_url": "https://clinicaltrials.gov/study/NCT07278557",
"title": "Assessment of Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia Following Radiotherapy for Oropharynx Cancer",
"has_exemption": false,
"start_date": "2026-01-28",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06625190",
"publication_url": "https://clinicaltrials.gov/study/NCT06625190",
"title": "Allogeneic Stem Cell Transplantation Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion With Zoledronic Acid in Combination to Treat Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory Solid Tumors",
"has_exemption": false,
"start_date": "2026-02-11",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07318480",
"publication_url": "https://clinicaltrials.gov/study/NCT07318480",
"title": "Cognitively-enhanced tDCS of the Dorsolateral Prefrontal Cortex to Reduce Craving in Cocaine Addiction",
"has_exemption": false,
"start_date": "2026-02-25",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07290621",
"publication_url": "https://clinicaltrials.gov/study/NCT07290621",
"title": "Phase II Trial of Neoadjuvant Toripalimab in Combination With Chemotherapy Followed by Transoral Robotic Surgery or Risk/Response Stratified Chemoradiotherapy for Locoregional HPV16+ Oropharyngeal Cancer: TARGET HPV Cohort 2",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07300956",
"publication_url": "https://clinicaltrials.gov/study/NCT07300956",
"title": "Comparing Medication Treatments for Neurodevelopmental Differences in Young Children on Rates of Beneficial Response",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06871488",
"publication_url": "https://clinicaltrials.gov/study/NCT06871488",
"title": "Identification of Neural Markers of Aggression and Irritability and Their Capacity to Predict Treatment Response to CNS Stimulant Medication in Youth With ADHD",
"has_exemption": false,
"start_date": "2026-03-05",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06824649",
"publication_url": "https://clinicaltrials.gov/study/NCT06824649",
"title": "SMART Use of Biologics in Chronic Rhinosinusitis With Nasal Polyposis",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07318714",
"publication_url": "https://clinicaltrials.gov/study/NCT07318714",
"title": "A Phase 1/2 Multicenter, Open-label, Dose Escalation Study Followed by a Randomized, Double-blind Sham-controlled Dose Expansion Study to Evaluate the Safety, Tolerability and Efficacy of ASP2246 in Adult Participants Who Have Motor Dysfunction Associated With Late Subacute to Chronic Ischemic Stroke Due to Supratentorial Perforator Area Infarction",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Inc",
"sponsor_slug": "astellas-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07459647",
"publication_url": "https://clinicaltrials.gov/study/NCT07459647",
"title": "An Open-Label Study to Assess the Long-Term Safety, Tolerability, and Effectiveness of ML-007C-MA in Adult Participants With Schizophrenia",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "MapLight Therapeutics",
"sponsor_slug": "maplight-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07166393",
"publication_url": "https://clinicaltrials.gov/study/NCT07166393",
"title": "Multi-institutional Phase 2/3 Trial of Valproic Acid in Patients With Moderate to Severe Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07460375",
"publication_url": "https://clinicaltrials.gov/study/NCT07460375",
"title": "A First-in-Human Phase 1/2, Dose Escalation and Dose Expansion Study to Evaluate Safety, Tolerability, and Preliminary Efficacy of Claudin18.2 (CLDN18.2)-Directed Antibody-Drug Conjugate (ADC) LCB02A in Patients With CLDN18.2-positive Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "LigaChem Biosciences, Inc.",
"sponsor_slug": "ligachem-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07129759",
"publication_url": "https://clinicaltrials.gov/study/NCT07129759",
"title": "A Long-term Extension Study to Evaluate the Safety and Tolerability of Daily Oral LUM-201 in Children With Growth Hormone Deficiency (GHD)",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Lumos Pharma",
"sponsor_slug": "lumos-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06315322",
"publication_url": "https://clinicaltrials.gov/study/NCT06315322",
"title": "A MULTICENTER, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE LONG-TERM SAFETY AND TOLERABILITY OF BRIVARACETAM IN STUDY PARTICIPANTS WITH CHILDHOOD ABSENCE EPILEPSY OR JUVENILE ABSENCE EPILEPSY",
"has_exemption": false,
"start_date": "2024-07-10",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06532123",
"publication_url": "https://clinicaltrials.gov/study/NCT06532123",
"title": "Mechanisms of Improving Fecal Continence Muscles Motor Function in Health and Disease",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07206849",
"publication_url": "https://clinicaltrials.gov/study/NCT07206849",
"title": "A Phase 2 Study of Tovorafenib in Pediatric and Young Adult Patients Newly Diagnosed With High-Grade Glioma (HGG), Including Diffuse Intrinsic Pontine Glioma (DIPG), Which Harbor Alterations in the Mitogen-Activated Protein Kinase (MAPK) Pathway",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Nationwide Children's Hospital",
"sponsor_slug": "nationwide-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05713799",
"publication_url": "https://clinicaltrials.gov/study/NCT05713799",
"title": "Phase II Trial of the Combination of Alpha-lipoic Acid and Mirabegron in Women and in Men With Obesity",
"has_exemption": false,
"start_date": "2026-03-24",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06965114",
"publication_url": "https://clinicaltrials.gov/study/NCT06965114",
"title": "A Phase 1 Study of Combination Tovorafenib (DAY101) and Rituximab Treatment in Relapsed or Refractory Classical Hairy Cell Leukemia and Phase 2 Randomized Study Comparing Tovorafenib (DAY101) and Rituximab With Cladribine and Rituximab for Front-Line Treatment of Classical Hairy Cell Leukemia",
"has_exemption": false,
"start_date": "2026-06-27",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04200729",
"publication_url": "https://clinicaltrials.gov/study/NCT04200729",
"title": "Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis",
"has_exemption": false,
"start_date": "2027-03-01",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226869",
"publication_url": "https://clinicaltrials.gov/study/NCT07226869",
"title": "Computer Guided Microwave Liver Ablation",
"has_exemption": false,
"start_date": "2026-03-02",
"completion_date": "2030-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "NE Scientific INC",
"sponsor_slug": "ne-scientific-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05952557",
"publication_url": "https://clinicaltrials.gov/study/NCT05952557",
"title": "CAMBRIA-2: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients With ER+/HER2- Early Breast Cancer and an Intermediate-High or High Risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease",
"has_exemption": false,
"start_date": "2023-10-05",
"completion_date": "2030-03-04",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06899126",
"publication_url": "https://clinicaltrials.gov/study/NCT06899126",
"title": "A Phase 3, Multicenter, Randomized, Open-label Trial of Trastuzumab Deruxtecan in Combination With Pembrolizumab Versus Platinum-based Chemotherapy in Combination With Pembrolizumab, as First-line Therapy in Participants With Locally Advanced Unresectable or Metastatic HER2 Overexpressing and PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer (DESTINY-Lung06)",
"has_exemption": false,
"start_date": "2025-10-24",
"completion_date": "2030-03-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03148418",
"publication_url": "https://clinicaltrials.gov/study/NCT03148418",
"title": "An Open-Label, Multicenter Extension and Long-Term Observational Study in Patients Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study",
"has_exemption": false,
"start_date": "2017-09-20",
"completion_date": "2030-03-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06869551",
"publication_url": "https://clinicaltrials.gov/study/NCT06869551",
"title": "A Phase 3, Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Children and Adolescents From 5 to Less Than 18 Years of Age With Active Juvenile Psoriatic Arthritis",
"has_exemption": false,
"start_date": "2025-03-13",
"completion_date": "2030-03-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05837897",
"publication_url": "https://clinicaltrials.gov/study/NCT05837897",
"title": "A Phase 3, Multicenter, Randomized, Parallel-Group, Double-blind, Placebo-Controlled Induction Study Followed by an Open-label Extension Period to Evaluate the Efficacy and Safety of Intravenous Vedolizumab (300 mg) Infusion Treatment in Subjects in China With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2023-06-16",
"completion_date": "2030-03-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07424404",
"publication_url": "https://clinicaltrials.gov/study/NCT07424404",
"title": "A Phase 3 Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of KarXT in Adolescents (13 to 17 Years of Age) With Schizophrenia and KarXT+KarX-EC in Children and Adolescents (5 to 17 Years of Age) With Irritability Associated With Autism Spectrum Disorder",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-03-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Karuna Therapeutics",
"sponsor_slug": "karuna-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05785767",
"publication_url": "https://clinicaltrials.gov/study/NCT05785767",
"title": "A Randomized, Double-Blind Phase 2/3 Study of Fianlimab (Anti-LAG-3 Antibody) in Combination With Cemiplimab (Anti-PD-1 Antibody) Versus Cemiplimab Monotherapy in First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With Tumors Expressing PD-L1 ≥50%",
"has_exemption": false,
"start_date": "2023-06-30",
"completion_date": "2030-03-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05646381",
"publication_url": "https://clinicaltrials.gov/study/NCT05646381",
"title": "A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis [Lp(a)FRONTIERS CAVS]",
"has_exemption": false,
"start_date": "2024-03-07",
"completion_date": "2030-03-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07483307",
"publication_url": "https://clinicaltrials.gov/study/NCT07483307",
"title": "Impact of Neoadjuvant Endocrine Therapy on Surgical Outcomes in Patients With Stage 2 to 3 Invasive Lobular Carcinoma: A Prospective Study",
"has_exemption": false,
"start_date": "2026-03-13",
"completion_date": "2030-03-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06987539",
"publication_url": "https://clinicaltrials.gov/study/NCT06987539",
"title": "A Phase 2 Open-label Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children From 2 Years to Less Than 18 Years of Age With Generalized Myasthenia Gravis (gMG)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2030-03-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05691478",
"publication_url": "https://clinicaltrials.gov/study/NCT05691478",
"title": "A Feasibility and Randomized Phase 2/3 Study of the VEGFR2/MET Inhibitor Cabozantinib in Combination With Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma",
"has_exemption": false,
"start_date": "2023-03-03",
"completion_date": "2030-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06042569",
"publication_url": "https://clinicaltrials.gov/study/NCT06042569",
"title": "Dose Reduction of Docetaxel-Based Chemotherapy in Vulnerable Older Women With Early-Stage Breast Cancer (DOROTHY)",
"has_exemption": false,
"start_date": "2024-09-16",
"completion_date": "2030-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07253285",
"publication_url": "https://clinicaltrials.gov/study/NCT07253285",
"title": "Efficacy, Safety and Pharmacokinetics of Cagrilintide s.c. 2.4 mg as Monotherapy and in Combination With Semaglutide s.c. 2.4 mg (CagriSema) Once Weekly for Weight Management in Chidren and Adolescents With Overweight or Obesity",
"has_exemption": false,
"start_date": "2026-01-08",
"completion_date": "2030-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07178301",
"publication_url": "https://clinicaltrials.gov/study/NCT07178301",
"title": "Elective Neck Dosing in Low Risk Oropharyngeal Human Papillomavirus-Related Cancer Treatment (ENLIGHT): A Single Arm Prospective Phase II Assessing 30 Gy Elective Neck Dose",
"has_exemption": false,
"start_date": "2026-03-20",
"completion_date": "2030-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06347055",
"publication_url": "https://clinicaltrials.gov/study/NCT06347055",
"title": "Neuronavigated Non-invasive Brain Stimulation for Nicotine Dependence.",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2030-03-25",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Missouri-Columbia",
"sponsor_slug": "university-of-missouri-columbia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05352919",
"publication_url": "https://clinicaltrials.gov/study/NCT05352919",
"title": "A Multicenter, Randomized, Dose-Blind, Phase 3 Long-Term Extension Study to Evaluate Continuous Safety and Efficacy of Litifilimab (BIIB059) in Adult Participants With Active Systemic Lupus Erythematosus",
"has_exemption": false,
"start_date": "2022-06-10",
"completion_date": "2030-03-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222800",
"publication_url": "https://clinicaltrials.gov/study/NCT07222800",
"title": "AN INTERVENTIONAL, PHASE 3, DOUBLE-BLIND, RANDOMIZED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN TREATMENT-NAÏVE PARTICIPANTS WITH METASTATIC COLORECTAL CANCER",
"has_exemption": false,
"start_date": "2025-12-11",
"completion_date": "2030-03-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07404826",
"publication_url": "https://clinicaltrials.gov/study/NCT07404826",
"title": "A Randomized, Sham Controlled Clinical Trial to Assess the Effectiveness of a Positive End Expiratory Device for Accelerating and Maintaining Pulmonary Rehabilitation Gains",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2030-03-29",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06439693",
"publication_url": "https://clinicaltrials.gov/study/NCT06439693",
"title": "A Single-Arm, Phase II Study of Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer: The SAPPHO Study",
"has_exemption": false,
"start_date": "2024-08-08",
"completion_date": "2030-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02050113",
"publication_url": "https://clinicaltrials.gov/study/NCT02050113",
"title": "Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices",
"has_exemption": false,
"start_date": "2014-03-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Andres Schanzer",
"sponsor_slug": "andres-schanzer",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03048201",
"publication_url": "https://clinicaltrials.gov/study/NCT03048201",
"title": "Post-market Registry Study on the Physica System Total Knee Replacement",
"has_exemption": false,
"start_date": "2017-03-24",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Limacorporate S.p.a",
"sponsor_slug": "limacorporate-spa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03674372",
"publication_url": "https://clinicaltrials.gov/study/NCT03674372",
"title": "Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Right and Left Congenital Diaphragmatic Hernia (CDH)",
"has_exemption": false,
"start_date": "2018-11-16",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04683250",
"publication_url": "https://clinicaltrials.gov/study/NCT04683250",
"title": "Phase I/II Study of the Selective RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities",
"has_exemption": false,
"start_date": "2020-12-16",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Taiho Pharmaceutical Co., Ltd.",
"sponsor_slug": "taiho-pharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05286801",
"publication_url": "https://clinicaltrials.gov/study/NCT05286801",
"title": "A Phase 1/2 Study of Tiragolumab (NSC# 827799) and Atezolizumab (NSC# 783608) in Patients With Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors",
"has_exemption": false,
"start_date": "2022-11-17",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05259527",
"publication_url": "https://clinicaltrials.gov/study/NCT05259527",
"title": "Impact of Vitamin D Supplementation on Reported Rates of Taxane-Induced Neuropathy",
"has_exemption": false,
"start_date": "2022-12-19",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06153173",
"publication_url": "https://clinicaltrials.gov/study/NCT06153173",
"title": "A Phase II Trial of the MEK Inhibitor Mirdametinib in Histiocytic Disorders",
"has_exemption": false,
"start_date": "2024-02-05",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06013865",
"publication_url": "https://clinicaltrials.gov/study/NCT06013865",
"title": "An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)",
"has_exemption": false,
"start_date": "2024-04-05",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06424756",
"publication_url": "https://clinicaltrials.gov/study/NCT06424756",
"title": "Role of Mitochondria-derived Oxidative Stress on Microvascular Endothelial Function in Healthy Non-Hispanic Black and White Adults",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Georgia",
"sponsor_slug": "university-of-georgia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06802315",
"publication_url": "https://clinicaltrials.gov/study/NCT06802315",
"title": "A Phase II Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Myeloablative Fludarabine/Busulfan and Post-Transplant Cyclophosphamide (PTCY) for Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk AML, CML, and MDS",
"has_exemption": false,
"start_date": "2025-02-04",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06926790",
"publication_url": "https://clinicaltrials.gov/study/NCT06926790",
"title": "Neoadjuvant Nivolumab Plus Ipilimumab in Resectable Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-02-17",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The First Affiliated Hospital of Guangzhou Medical University",
"sponsor_slug": "the-first-affiliated-hospital-of-guangzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06805305",
"publication_url": "https://clinicaltrials.gov/study/NCT06805305",
"title": "Randomized Study of DOC1021 Dendritic Cell Immunotherapy in Combination With Standard of Care for Newly Diagnosed Adult Glioblastoma",
"has_exemption": false,
"start_date": "2025-03-17",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Diakonos Oncology Corporation",
"sponsor_slug": "diakonos-oncology-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06847269",
"publication_url": "https://clinicaltrials.gov/study/NCT06847269",
"title": "CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia: An Investigation of Lymphodepleting Chemotherapy Pharmacokinetics",
"has_exemption": false,
"start_date": "2025-05-21",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07076342",
"publication_url": "https://clinicaltrials.gov/study/NCT07076342",
"title": "Mechanistic Clinical Trial Evaluating the Role of the Metabotropic Glutamate Receptor Subtype 5 (mGluR5) in the Antidepressant Mechanism of Cognitive Behavioral Therapy for Insomnia (CBT-I)",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stony Brook University",
"sponsor_slug": "stony-brook-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07193511",
"publication_url": "https://clinicaltrials.gov/study/NCT07193511",
"title": "A Phase 1/2, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-103, a Nectin4/Trop2 ADC, as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors",
"has_exemption": false,
"start_date": "2025-10-02",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Avenzo Therapeutics, Inc.",
"sponsor_slug": "avenzo-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06937866",
"publication_url": "https://clinicaltrials.gov/study/NCT06937866",
"title": "Maintenance Zanzalintinib With Oral Etoposide Following High-dose Chemotherapy in Patients With Relapsed Metastatic Germ-cell Tumor",
"has_exemption": false,
"start_date": "2025-11-12",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07108270",
"publication_url": "https://clinicaltrials.gov/study/NCT07108270",
"title": "A Phase 2, Multicenter, Open-label, Single Arm Study of Dostarlimab Plus Carboplatin-paclitaxel Followed by Dostarlimab Monotherapy in Participants With dMMR/MSI-H Primary Advanced or Recurrent Endometrial Cancer in China (China RUBY)",
"has_exemption": false,
"start_date": "2025-11-27",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07159841",
"publication_url": "https://clinicaltrials.gov/study/NCT07159841",
"title": "A Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Atumelnant Treatment in Pediatric Participants With Congenital Adrenal Hyperplasia Including a Long-Term Extension",
"has_exemption": false,
"start_date": "2026-01-22",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Crinetics Pharmaceuticals Inc.",
"sponsor_slug": "crinetics-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07286006",
"publication_url": "https://clinicaltrials.gov/study/NCT07286006",
"title": "A Long-Term Extension Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Patients With Graves' Disease",
"has_exemption": false,
"start_date": "2026-01-26",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Immunovant Sciences GmbH",
"sponsor_slug": "immunovant-sciences-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284758",
"publication_url": "https://clinicaltrials.gov/study/NCT07284758",
"title": "A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-02-18",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "C4 Therapeutics, Inc.",
"sponsor_slug": "c4-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07464886",
"publication_url": "https://clinicaltrials.gov/study/NCT07464886",
"title": "Prefrontal Glutamatergic Modulation by N-acetylcysteine and Mindfulness-based Cognitive Therapy for Mild Depression in Youth",
"has_exemption": false,
"start_date": "2026-02-26",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Cincinnati",
"sponsor_slug": "university-of-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07432295",
"publication_url": "https://clinicaltrials.gov/study/NCT07432295",
"title": "A Randomized, Multicenter, Open-Label, Phase 2 Study of Givastomig (TJ033721) in Combination With Nivolumab and Chemotherapy Versus Nivolumab and Chemotherapy in Participants With Previously Untreated CLDN18.2 Positive and PD-1L Positive Locally Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Junction Adenocarcinoma",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "I-Mab Biopharma US Limited",
"sponsor_slug": "i-mab-biopharma-us-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07281027",
"publication_url": "https://clinicaltrials.gov/study/NCT07281027",
"title": "Comparing the Effects of Anakinra and Tocilizumab on Outcomes in Patients With New-Onset Refractory Status Epilepticus",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07158242",
"publication_url": "https://clinicaltrials.gov/study/NCT07158242",
"title": "A Phase III Randomized Double-Blind Multi-Center Treat-Through Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Children Aged 2 - 17 Years With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07262060",
"publication_url": "https://clinicaltrials.gov/study/NCT07262060",
"title": "Optimizing Caffeine Therapy for Hypoxia in Preterm Neonates: A Randomized Trial Assessing Efficacy, Acute Kidney and Brain Injury, Safety, and Pharmacokinetics",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07281768",
"publication_url": "https://clinicaltrials.gov/study/NCT07281768",
"title": "Combining Capecitabine/Oxaliplatin Chemotherapy With Cemiplimab Alone or in Combination With Fianlimab or REGN7075 for the Neoadjuvant Treatment of Locally Advanced Rectal Cancer",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07346144",
"publication_url": "https://clinicaltrials.gov/study/NCT07346144",
"title": "A Phase I/II Study of an AAV-1 Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Trogenix ltd",
"sponsor_slug": "trogenix-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07470606",
"publication_url": "https://clinicaltrials.gov/study/NCT07470606",
"title": "Memory RT: Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center at San Antonio",
"sponsor_slug": "the-university-of-texas-health-science-center-at-san-antonio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07187466",
"publication_url": "https://clinicaltrials.gov/study/NCT07187466",
"title": "Sequential Multiple Assignment Randomized Trial to Treat Urinary Symptoms in Parkinson Disease",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07448974",
"publication_url": "https://clinicaltrials.gov/study/NCT07448974",
"title": "Vitamin D and Type 2 Diabetes, Treat-To-Target",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tufts Medical Center",
"sponsor_slug": "tufts-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04042402",
"publication_url": "https://clinicaltrials.gov/study/NCT04042402",
"title": "An Open-Label Roll-Over Study to Evaluate the Long-Term Safety and Efficacy of DCR-PHXC Solution for Injection (Subcutaneous Use) in Patients With Primary Hyperoxaluria",
"has_exemption": false,
"start_date": "2019-07-09",
"completion_date": "2030-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dicerna Pharmaceuticals, Inc., a Novo Nordisk company",
"sponsor_slug": "dicerna-pharmaceuticals-inc-a-novo-nordisk-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07112287",
"publication_url": "https://clinicaltrials.gov/study/NCT07112287",
"title": "MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Christopher Reilly",
"sponsor_slug": "christopher-reilly",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06077071",
"publication_url": "https://clinicaltrials.gov/study/NCT06077071",
"title": "MRIdian \"RADAR\" Trial - Radiosurgical Debulking of Asymptomatic/Radiographic Spinal Cord Compression Using Stereotactic MRI-guided Adaptive Radiotherapy",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2030-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07029776",
"publication_url": "https://clinicaltrials.gov/study/NCT07029776",
"title": "A Phase 2 Study Exploring the Use of Bispecific Antibodies to Improve Progression Free Survival in Patients With High-Risk Newly Diagnosed Multiple Myeloma (MMulti-Immune HR)",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2030-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arkansas",
"sponsor_slug": "university-of-arkansas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05972629",
"publication_url": "https://clinicaltrials.gov/study/NCT05972629",
"title": "A Phase 1/Phase 2, Open-label, Dose-escalation, and Dose Expansion Study to Evaluate the Safety, Tolerability, and Efficacy of SAR444836, an Adeno-associated Viral Vector-mediated Gene Transfer of Human Phenylalanine Hydroxylase, in Adult Participants With Phenylketonuria",
"has_exemption": false,
"start_date": "2023-08-07",
"completion_date": "2030-04-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07326709",
"publication_url": "https://clinicaltrials.gov/study/NCT07326709",
"title": "A Randomized, Placebo-controlled, Double-blind Phase 3 Study to Evaluate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2030-04-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06133972",
"publication_url": "https://clinicaltrials.gov/study/NCT06133972",
"title": "A Randomized, Double-blind, Placebo-controlled Extension Study to Assess the Long-term Safety and Tolerability of Ianalumab in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE Extension)",
"has_exemption": false,
"start_date": "2024-05-21",
"completion_date": "2030-04-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03718403",
"publication_url": "https://clinicaltrials.gov/study/NCT03718403",
"title": "Effect of Theophylline in Pseudohypoparathyroidism",
"has_exemption": false,
"start_date": "2019-11-11",
"completion_date": "2030-04-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05582993",
"publication_url": "https://clinicaltrials.gov/study/NCT05582993",
"title": "A Phase 3, Prospective, Open-label, Uncontrolled, Multicenter Study on Efficacy and Safety of Prophylaxis With Vonicog Alfa (rVWF) in Children Diagnosed With Severe Von Willebrand Disease",
"has_exemption": false,
"start_date": "2024-11-06",
"completion_date": "2030-04-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06632977",
"publication_url": "https://clinicaltrials.gov/study/NCT06632977",
"title": "PREcision DIagnostics in Prostate Cancer Treatment (PREDICT)",
"has_exemption": false,
"start_date": "2025-02-06",
"completion_date": "2030-04-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance for Clinical Trials in Oncology",
"sponsor_slug": "alliance-for-clinical-trials-in-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07061574",
"publication_url": "https://clinicaltrials.gov/study/NCT07061574",
"title": "A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes",
"has_exemption": false,
"start_date": "2026-03-30",
"completion_date": "2030-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06397703",
"publication_url": "https://clinicaltrials.gov/study/NCT06397703",
"title": "A Phase II Prospective 2-Arm Cohort Interventional Trial Utilizing Ultra-Hypofractionated SBRT With or Without Short Course Androgen Deprivation Therapy For Unfavorable Intermediate Risk Prostate Cancer",
"has_exemption": false,
"start_date": "2024-04-16",
"completion_date": "2030-04-16",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06686394",
"publication_url": "https://clinicaltrials.gov/study/NCT06686394",
"title": "HERTHENA-Breast-01: A Phase 1b/2, Multicenter, Open-label, Dose-Finding Study to Evaluate the Safety and Antitumor Activity of Patritumab Deruxtecan in Participants With HER2 Positive Unresectable Locally Advanced Breast Cancer or Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2025-02-26",
"completion_date": "2030-04-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07153497",
"publication_url": "https://clinicaltrials.gov/study/NCT07153497",
"title": "A Randomized Phase 2 Trial of Olutasidenib-Based Therapies in Patients With Newly Diagnosed IDH1-Mutant Myeloid Malignancies: A MyeloMATCH Substudy",
"has_exemption": false,
"start_date": "2026-05-27",
"completion_date": "2030-04-26",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03547973",
"publication_url": "https://clinicaltrials.gov/study/NCT03547973",
"title": "A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer",
"has_exemption": false,
"start_date": "2018-08-13",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04806854",
"publication_url": "https://clinicaltrials.gov/study/NCT04806854",
"title": "A Single-Center, Randomized, Open-Label, Parallel Arm Study of Daily Oral LUM-201 in Naive-to-Treatment, Prepubertal Children With Idiopathic Pediatric Growth Hormone Deficiency (PGHD)",
"has_exemption": false,
"start_date": "2021-07-14",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Lumos Pharma",
"sponsor_slug": "lumos-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05919108",
"publication_url": "https://clinicaltrials.gov/study/NCT05919108",
"title": "Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers",
"has_exemption": false,
"start_date": "2024-05-30",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt-Ingram Cancer Center",
"sponsor_slug": "vanderbilt-ingram-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06322108",
"publication_url": "https://clinicaltrials.gov/study/NCT06322108",
"title": "Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)",
"has_exemption": false,
"start_date": "2024-06-13",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Immune Oncology Research Institute",
"sponsor_slug": "immune-oncology-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06721689",
"publication_url": "https://clinicaltrials.gov/study/NCT06721689",
"title": "A Phase 1/2 Clinical Trial of the Novel Topoisomerase I Inhibitor PEEL-224 as a Single Agent and in Combination With Vincristine and Temozolomide in Children With Refractory, Progressive or Relapsed Solid Tumors",
"has_exemption": false,
"start_date": "2025-03-23",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Theodore Laetsch",
"sponsor_slug": "theodore-laetsch",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06861920",
"publication_url": "https://clinicaltrials.gov/study/NCT06861920",
"title": "Targeting Interindividual Variability in NSAID Responses to Mitigate Chronic Pelvic Pain Risk in Dysmenorrhea (NSAID HEAL)",
"has_exemption": false,
"start_date": "2025-04-07",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Endeavor Health",
"sponsor_slug": "endeavor-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06884423",
"publication_url": "https://clinicaltrials.gov/study/NCT06884423",
"title": "Infant Survival and Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia, A Phase III Trial",
"has_exemption": false,
"start_date": "2025-04-07",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Holly L Hedrick, MD",
"sponsor_slug": "holly-l-hedrick-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06892678",
"publication_url": "https://clinicaltrials.gov/study/NCT06892678",
"title": "DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma",
"has_exemption": false,
"start_date": "2025-04-07",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Montefiore Medical Center",
"sponsor_slug": "montefiore-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06702033",
"publication_url": "https://clinicaltrials.gov/study/NCT06702033",
"title": "Phase II Trial of Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: \"The Minimalist Trial-2 (MINT-2)\"",
"has_exemption": false,
"start_date": "2025-04-10",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06946576",
"publication_url": "https://clinicaltrials.gov/study/NCT06946576",
"title": "Infant Survival and Long-term Outcomes Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia, A Phase III Trial",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Oregon Health and Science University",
"sponsor_slug": "oregon-health-and-science-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07231497",
"publication_url": "https://clinicaltrials.gov/study/NCT07231497",
"title": "Cognitive Strategies in Early Psychosis 1",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284589",
"publication_url": "https://clinicaltrials.gov/study/NCT07284589",
"title": "Evaluation of Ultralow Dose PET Imaging for Detecting SSTR2 Radiotracer Uptake",
"has_exemption": false,
"start_date": "2025-12-11",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Akiva Mintz",
"sponsor_slug": "akiva-mintz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06666348",
"publication_url": "https://clinicaltrials.gov/study/NCT06666348",
"title": "A Phase 1/2 Study of Mirdametinib and Vinblastine for Newly Diagnosed or Previously Untreated Patients With Pediatric Low-grade Glioma and Activation of the MAPK Pathway",
"has_exemption": false,
"start_date": "2026-01-12",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Justine's Hospital",
"sponsor_slug": "st-justines-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07469384",
"publication_url": "https://clinicaltrials.gov/study/NCT07469384",
"title": "Sensory Contributions to Third Visual Pathway Dysfunction in Schizophrenia: Correlation and Causation",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Nathan Kline Institute for Psychiatric Research",
"sponsor_slug": "nathan-kline-institute-for-psychiatric-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07263022",
"publication_url": "https://clinicaltrials.gov/study/NCT07263022",
"title": "Cognitive Strategies in Early Psychosis 2",
"has_exemption": false,
"start_date": "2026-04-13",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05763693",
"publication_url": "https://clinicaltrials.gov/study/NCT05763693",
"title": "Vitality in Infants Via Azithromycin for Neonates Trial",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07126158",
"publication_url": "https://clinicaltrials.gov/study/NCT07126158",
"title": "Phase II Study of Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218575",
"publication_url": "https://clinicaltrials.gov/study/NCT07218575",
"title": "A Randomized, Placebo Controlled Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Children’s Hospital",
"sponsor_slug": "boston-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07191717",
"publication_url": "https://clinicaltrials.gov/study/NCT07191717",
"title": "Phase II Minimal Residual Disease Study of Selective Estrogen Receptor Degrader Imlunestrant With Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Abemaciclib in Patients With ER+ Breast Cancer (MIRI)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07212998",
"publication_url": "https://clinicaltrials.gov/study/NCT07212998",
"title": "Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) Trial",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jason Sperry",
"sponsor_slug": "jason-sperry",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07475286",
"publication_url": "https://clinicaltrials.gov/study/NCT07475286",
"title": "A Phase II Single Arm Study of Combined Systemic and Intraperitoneal Chemotherapy for Synchronous Gastric and/or Gastroesophageal Peritoneal Carcinomatosis",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mohammad Haroon Asif Choudry",
"sponsor_slug": "mohammad-haroon-asif-choudry",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07421518",
"publication_url": "https://clinicaltrials.gov/study/NCT07421518",
"title": "Ketone Monitoring Approaches for Diabetic Ketoacidosis Risk Mitigation in People With T1D on Adjunctive SGLT2 Inhibitors",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AdventHealth Translational Research Institute",
"sponsor_slug": "adventhealth-translational-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03346694",
"publication_url": "https://clinicaltrials.gov/study/NCT03346694",
"title": "Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing",
"has_exemption": false,
"start_date": "2018-05-01",
"completion_date": "2030-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05285891",
"publication_url": "https://clinicaltrials.gov/study/NCT05285891",
"title": "Randomized, Blinded Discontinuation Trial of Ocrelizumab in Early Relapsing Multiple Sclerosis (AMS05)",
"has_exemption": false,
"start_date": "2023-01-12",
"completion_date": "2030-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07118839",
"publication_url": "https://clinicaltrials.gov/study/NCT07118839",
"title": "MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use Disorder: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-04-15",
"completion_date": "2030-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06585410",
"publication_url": "https://clinicaltrials.gov/study/NCT06585410",
"title": "A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC)",
"has_exemption": false,
"start_date": "2025-01-02",
"completion_date": "2030-05-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05692180",
"publication_url": "https://clinicaltrials.gov/study/NCT05692180",
"title": "Efficacy and Safety of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)",
"has_exemption": false,
"start_date": "2023-04-05",
"completion_date": "2030-05-05",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06663722",
"publication_url": "https://clinicaltrials.gov/study/NCT06663722",
"title": "A Phase II b Study of Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease",
"has_exemption": false,
"start_date": "2025-05-05",
"completion_date": "2030-05-05",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222189",
"publication_url": "https://clinicaltrials.gov/study/NCT07222189",
"title": "A Multinational, Multicenter Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Adults With Crohn's Disease or Ulcerative Colitis",
"has_exemption": false,
"start_date": "2026-05-12",
"completion_date": "2030-05-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223190",
"publication_url": "https://clinicaltrials.gov/study/NCT07223190",
"title": "A Phase 3, Open-label, Randomized, Controlled Trial of Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With Philadelphia Chromosome Negative B-cell Precursor Acute Lymphoblastic Leukaemia",
"has_exemption": false,
"start_date": "2026-06-11",
"completion_date": "2030-05-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06841354",
"publication_url": "https://clinicaltrials.gov/study/NCT06841354",
"title": "A Phase 3, Randomized, Open-label Study Comparing Efficacy and Safety of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as a Monotherapy and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With Previously Untreated Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer Expressing PD-L1 at CPS Less Than 10 (TroFuse-011)",
"has_exemption": false,
"start_date": "2025-03-16",
"completion_date": "2030-05-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07447817",
"publication_url": "https://clinicaltrials.gov/study/NCT07447817",
"title": "Investigator-Initiated, Open-Label, Phase II Trial of Selinexor in Combination With Pacritinib in Patients With Myelofibrosis Who Are JAK Inhibitor-Naïve and Have Cytopenias (ILLUMINATE)",
"has_exemption": false,
"start_date": "2026-05-04",
"completion_date": "2030-05-24",
"has_results": false,
"results_due": false,
"sponsor_name": "John Mascarenhas",
"sponsor_slug": "john-mascarenhas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06932757",
"publication_url": "https://clinicaltrials.gov/study/NCT06932757",
"title": "Phase 2 Trial of Adjuvant Quisinostat in High-Risk Uveal Melanoma",
"has_exemption": false,
"start_date": "2025-05-27",
"completion_date": "2030-05-27",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05061550",
"publication_url": "https://clinicaltrials.gov/study/NCT05061550",
"title": "A Phase II, Open-label, Multicentre, Randomised Study of Neoadjuvant and Adjuvant Treatment in Patients With Resectable, Early-stage (II to IIIB) Non-small Cell Lung Cancer (NeoCOAST-2)",
"has_exemption": false,
"start_date": "2022-04-14",
"completion_date": "2030-05-28",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07052903",
"publication_url": "https://clinicaltrials.gov/study/NCT07052903",
"title": "TRITON-CM: A Phase 3 Global, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Transthyretin-Mediated Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)",
"has_exemption": false,
"start_date": "2025-07-02",
"completion_date": "2030-05-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Alnylam Pharmaceuticals",
"sponsor_slug": "alnylam-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03701334",
"publication_url": "https://clinicaltrials.gov/study/NCT03701334",
"title": "A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negative Early Breast Cancer (New Adjuvant TriAl With Ribociclib [LEE011]: NATALEE)",
"has_exemption": false,
"start_date": "2018-12-07",
"completion_date": "2030-05-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06117774",
"publication_url": "https://clinicaltrials.gov/study/NCT06117774",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Who Have Not Progressed Following Concurrent Chemoradiation Therapy",
"has_exemption": false,
"start_date": "2024-02-20",
"completion_date": "2030-05-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05775367",
"publication_url": "https://clinicaltrials.gov/study/NCT05775367",
"title": "Cochlear Implantation in Infants and Toddlers With Single-Sided Deafness",
"has_exemption": false,
"start_date": "2023-07-07",
"completion_date": "2030-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02115295",
"publication_url": "https://clinicaltrials.gov/study/NCT02115295",
"title": "Phase II Study of Cladribine Plus Idarubicin Plus Cytarabine (ARAC) in Patients With AML, HR MDS, or Myeloid Blast Phase of CML",
"has_exemption": false,
"start_date": "2014-05-19",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02310399",
"publication_url": "https://clinicaltrials.gov/study/NCT02310399",
"title": "Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves",
"has_exemption": false,
"start_date": "2014-05-31",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03394365",
"publication_url": "https://clinicaltrials.gov/study/NCT03394365",
"title": "Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab or Rituximab and Chemotherapy",
"has_exemption": false,
"start_date": "2017-12-29",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pierre Fabre Medicament",
"sponsor_slug": "pierre-fabre-medicament",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03618186",
"publication_url": "https://clinicaltrials.gov/study/NCT03618186",
"title": "Neuroimaging Study",
"has_exemption": false,
"start_date": "2018-11-26",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03821857",
"publication_url": "https://clinicaltrials.gov/study/NCT03821857",
"title": "Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease",
"has_exemption": false,
"start_date": "2019-06-27",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03972202",
"publication_url": "https://clinicaltrials.gov/study/NCT03972202",
"title": "The Role of Cerebellum in Speech",
"has_exemption": false,
"start_date": "2019-09-15",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05951179",
"publication_url": "https://clinicaltrials.gov/study/NCT05951179",
"title": "A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of Intravesical Instillation of TARA-002 in Adults With High-Grade Non-Muscle Invasive Bladder Cancer",
"has_exemption": false,
"start_date": "2023-09-15",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Protara Therapeutics",
"sponsor_slug": "protara-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06492304",
"publication_url": "https://clinicaltrials.gov/study/NCT06492304",
"title": "A Phase 1/2 Dose Evaluation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD70 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX131) in Adult Subjects With Relapsed/Refractory Hematologic Malignancies",
"has_exemption": false,
"start_date": "2024-08-13",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CRISPR Therapeutics",
"sponsor_slug": "crispr-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06851338",
"publication_url": "https://clinicaltrials.gov/study/NCT06851338",
"title": "Pediatric Down Syndrome Post-Approval Study",
"has_exemption": false,
"start_date": "2025-02-28",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Inspire Medical Systems, Inc.",
"sponsor_slug": "inspire-medical-systems-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07010692",
"publication_url": "https://clinicaltrials.gov/study/NCT07010692",
"title": "Using Fractional Lasers and Tirbanibulin Ointment to Treat Keratinocyte Carcinomas",
"has_exemption": false,
"start_date": "2025-05-16",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Bruce Robinson, MD",
"sponsor_slug": "bruce-robinson-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06876662",
"publication_url": "https://clinicaltrials.gov/study/NCT06876662",
"title": "Long-Term Safety of Pirtobrutinib in Participants From Study LOXO-BTK-18001 With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06876649",
"publication_url": "https://clinicaltrials.gov/study/NCT06876649",
"title": "A Master Protocol to Evaluate the Long-Term Safety of Pirtobrutinib",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06961955",
"publication_url": "https://clinicaltrials.gov/study/NCT06961955",
"title": "FAST NOVEMBER: A Phase II Randomized Trial of a 5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer",
"has_exemption": false,
"start_date": "2025-05-21",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07162181",
"publication_url": "https://clinicaltrials.gov/study/NCT07162181",
"title": "Long-Term Safety of Pirtobrutinib in Participants From Study J2N-MC-JZNJ With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06814496",
"publication_url": "https://clinicaltrials.gov/study/NCT06814496",
"title": "RAdiation comBined With BIspecific T-Cell Engager in DLL3 Expressing Tumors (RABBIT) Study: A Phase I/II Study of AMG757 / Tarlatamab and Concurrent Radiation Therapy in Tumors With High Prevalence of DLL3",
"has_exemption": false,
"start_date": "2025-09-08",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07186842",
"publication_url": "https://clinicaltrials.gov/study/NCT07186842",
"title": "First-in-human, Open-label, Multi-site, Phase I/IIa, Dose Escalation Trial With Expansion Cohorts to Evaluate Safety and Preliminary Efficacy of BNT329 in Participants With Advanced Solid Tumors Known to Express CA19-9",
"has_exemption": false,
"start_date": "2025-11-18",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07097363",
"publication_url": "https://clinicaltrials.gov/study/NCT07097363",
"title": "A Pilot Study of Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for Upfront Treatment of Aggressive B-Cell Non-Hodgkin Lymphomas",
"has_exemption": false,
"start_date": "2025-12-07",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224438",
"publication_url": "https://clinicaltrials.gov/study/NCT07224438",
"title": "Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea",
"has_exemption": false,
"start_date": "2025-12-09",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stephanie B. Seminara, MD",
"sponsor_slug": "stephanie-b-seminara-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07340554",
"publication_url": "https://clinicaltrials.gov/study/NCT07340554",
"title": "Neuroimaging of Instrumental Learning Networks in Adolescent Cannabis Use Treatment",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06410001",
"publication_url": "https://clinicaltrials.gov/study/NCT06410001",
"title": "CE-STAND: Cervical Epidural STimulation After Neurologic Damage",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218341",
"publication_url": "https://clinicaltrials.gov/study/NCT07218341",
"title": "Long-Term Safety of Pirtobrutinib in Participants From Study LOXO-BTK-20020 With BTKi Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07298421",
"publication_url": "https://clinicaltrials.gov/study/NCT07298421",
"title": "A Phase III Randomized Double-Blind Multi-Center Treat-Through Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Children Aged 2-17 Years With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2026-05-29",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07467707",
"publication_url": "https://clinicaltrials.gov/study/NCT07467707",
"title": "A Phase 3b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of an Adjuvanted Chikungunya Virus Virus-like Particle (CHIKV VLP) Vaccine for the Prevention of Chikungunya Disease in Adolescents (12 to <18 Years) and Adults (≥18 Years)",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Bavarian Nordic",
"sponsor_slug": "bavarian-nordic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07087938",
"publication_url": "https://clinicaltrials.gov/study/NCT07087938",
"title": "Safety and Behavioral Pharmacology of Cannabichromene as an Adjunct to Rheumatoid Arthritis Treatment; Effects on Inflammatory Markers and Rheumatoid Arthritis Disease Activity",
"has_exemption": false,
"start_date": "2028-07-15",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Crystal Lederhos Smith",
"sponsor_slug": "crystal-lederhos-smith",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04900623",
"publication_url": "https://clinicaltrials.gov/study/NCT04900623",
"title": "Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study",
"has_exemption": false,
"start_date": "2021-07-02",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonathan Schoenfeld, MD, MPH",
"sponsor_slug": "jonathan-schoenfeld-md-mph",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07060066",
"publication_url": "https://clinicaltrials.gov/study/NCT07060066",
"title": "Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia",
"has_exemption": false,
"start_date": "2024-05-21",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06872333",
"publication_url": "https://clinicaltrials.gov/study/NCT06872333",
"title": "Allogeneic Hematopoietic Stem Cell Transplant for Patients With High Risk Hemoglobinopathies and Other Red Cell Transfusion Dependent Disorders",
"has_exemption": false,
"start_date": "2024-11-19",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Masonic Cancer Center, University of Minnesota",
"sponsor_slug": "masonic-cancer-center-university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06810778",
"publication_url": "https://clinicaltrials.gov/study/NCT06810778",
"title": "Phase I/II Study of Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)",
"has_exemption": false,
"start_date": "2025-05-02",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06996730",
"publication_url": "https://clinicaltrials.gov/study/NCT06996730",
"title": "A Double-Blind, Placebo-Controlled, Double-Dummy Study of Donanemab and RG6289 in PSEN1 E280A Mutation Carriers, and in Non-Randomized, Placebo-Treated Non-Carriers From the Same Kindred, to Evaluate the Efficacy and Safety of Donanemab, RG6289, or the Combination of Donanemab and RG6289, in the Treatment of Autosomal-Dominant Alzheimer's Disease",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Banner Health",
"sponsor_slug": "banner-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07420218",
"publication_url": "https://clinicaltrials.gov/study/NCT07420218",
"title": "Impact of FSH and Estradiol on Sympathetic Function in Menopausal Women",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Delaware",
"sponsor_slug": "university-of-delaware",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07142551",
"publication_url": "https://clinicaltrials.gov/study/NCT07142551",
"title": "Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response Via Modulation of ANdrogen Receptor (the SPIDERMAN Trial)",
"has_exemption": false,
"start_date": "2026-03-09",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06800092",
"publication_url": "https://clinicaltrials.gov/study/NCT06800092",
"title": "Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment",
"has_exemption": false,
"start_date": "2026-03-15",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Medical Branch, Galveston",
"sponsor_slug": "the-university-of-texas-medical-branch-galveston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04457076",
"publication_url": "https://clinicaltrials.gov/study/NCT04457076",
"title": "A Phase 3, Prospective, Multi-Center, Single-Arm, Open-Label Study to Evaluate LevoCept™, a Long-Acting Reversible Intrauterine System for Contraceptive Efficacy, Safety, and Tolerability",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sebela Women's Health Inc.",
"sponsor_slug": "sebela-womens-health-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05998408",
"publication_url": "https://clinicaltrials.gov/study/NCT05998408",
"title": "A Phase I/II Study of the JAK1/2 Inhibitor Ruxolitinib for Relapsed / Refractory Immune Bone Marrow Failure",
"has_exemption": false,
"start_date": "2024-02-20",
"completion_date": "2030-06-03",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07019454",
"publication_url": "https://clinicaltrials.gov/study/NCT07019454",
"title": "Baystate Health Physician Sponsored - Investigational Device Exception: Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysms",
"has_exemption": false,
"start_date": "2025-06-03",
"completion_date": "2030-06-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Baystate Medical Center",
"sponsor_slug": "baystate-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07154290",
"publication_url": "https://clinicaltrials.gov/study/NCT07154290",
"title": "A Phase 2 Study to Investigate Ubamatamab With and Without REGN7075 in Treatment-Experienced Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2026-03-18",
"completion_date": "2030-06-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226999",
"publication_url": "https://clinicaltrials.gov/study/NCT07226999",
"title": "A GLOBAL PHASE 2/3 INTERVENTIONAL STUDY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY IN PARTICIPANTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER",
"has_exemption": false,
"start_date": "2025-12-09",
"completion_date": "2030-06-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04452591",
"publication_url": "https://clinicaltrials.gov/study/NCT04452591",
"title": "A Phase 3 Study of Cretostimogene Grenadenorepvec in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus-Calmette-Guerin (BCG)",
"has_exemption": false,
"start_date": "2020-10-27",
"completion_date": "2030-06-16",
"has_results": false,
"results_due": false,
"sponsor_name": "CG Oncology, Inc.",
"sponsor_slug": "cg-oncology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05987449",
"publication_url": "https://clinicaltrials.gov/study/NCT05987449",
"title": "A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A",
"has_exemption": false,
"start_date": "2023-09-21",
"completion_date": "2030-06-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07116616",
"publication_url": "https://clinicaltrials.gov/study/NCT07116616",
"title": "A Phase 1/2, Open-label, Multicenter Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2030-06-17",
"has_results": false,
"results_due": false,
"sponsor_name": "ModernaTX, Inc.",
"sponsor_slug": "modernatx-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06077760",
"publication_url": "https://clinicaltrials.gov/study/NCT06077760",
"title": "A Phase 3, Randomized, Double-blind, Placebo- and Active-Comparator-Controlled Clinical Study of Adjuvant V940 (mRNA-4157) Plus Pembrolizumab Versus Adjuvant Placebo Plus Pembrolizumab in Participants With Resected Stage II, IIIA, IIIB (N2) Non-small Cell Lung Cancer (INTerpath-002)",
"has_exemption": false,
"start_date": "2023-12-06",
"completion_date": "2030-06-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06578247",
"publication_url": "https://clinicaltrials.gov/study/NCT06578247",
"title": "A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial Of Quizartinib Administered in Combination With Induction and Consolidation Chemotherapy and Administered as Maintenance Therapy in Adult Patients With Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2024-11-19",
"completion_date": "2030-06-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07029828",
"publication_url": "https://clinicaltrials.gov/study/NCT07029828",
"title": "A LONG-TERM, DOUBLE-BLIND EXTENSION STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF RITLECITINIB IN PARTICIPANTS WITH SEVERE ALOPECIA AREATA WHO PREVIOUSLY COMPLETED STUDIES B7981027 OR B7981031",
"has_exemption": false,
"start_date": "2025-09-10",
"completion_date": "2030-06-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04004169",
"publication_url": "https://clinicaltrials.gov/study/NCT04004169",
"title": "Closed-Loop Deep Brain Stimulation for Treatment-Resistant Depression",
"has_exemption": false,
"start_date": "2019-07-18",
"completion_date": "2030-06-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Andrew Krystal",
"sponsor_slug": "andrew-krystal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05161195",
"publication_url": "https://clinicaltrials.gov/study/NCT05161195",
"title": "A Post-trial Access Roll-over Study to Allow Access to Ribociclib (LEE011) for Patients Who Are on Ribociclib Treatment in Novartis-sponsored Study",
"has_exemption": false,
"start_date": "2022-07-07",
"completion_date": "2030-06-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07127913",
"publication_url": "https://clinicaltrials.gov/study/NCT07127913",
"title": "Closed-Loop Deep Brain Stimulation for Bipolar Depression (PReSiDio-BP)",
"has_exemption": false,
"start_date": "2025-07-16",
"completion_date": "2030-06-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Andrew Krystal",
"sponsor_slug": "andrew-krystal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06994845",
"publication_url": "https://clinicaltrials.gov/study/NCT06994845",
"title": "A Single-arm, Multicenter, Phase III Study to Assess Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients of 2 to <18 Years of Age With Primary Immunoglobulin A Nephropathy (IgAN)",
"has_exemption": false,
"start_date": "2025-11-27",
"completion_date": "2030-06-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06966362",
"publication_url": "https://clinicaltrials.gov/study/NCT06966362",
"title": "Varenicline for Smoking Reduction in Veterans Unwilling to Quit",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2030-06-28",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03971669",
"publication_url": "https://clinicaltrials.gov/study/NCT03971669",
"title": "Collection of Blood Samples for In-Vitro Studies from Healthy Adult Blood Donors Who Have Received Oral Typhoid Vaccine (TY21A)",
"has_exemption": false,
"start_date": "2004-01-16",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01630850",
"publication_url": "https://clinicaltrials.gov/study/NCT01630850",
"title": "Islet Transplantation in Patients With \"Brittle\" Type I Diabetes",
"has_exemption": false,
"start_date": "2012-05-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04305145",
"publication_url": "https://clinicaltrials.gov/study/NCT04305145",
"title": "Phase II Study of Infliximab for the Treatment of Immune Checkpoint Inhibitor Colitis",
"has_exemption": false,
"start_date": "2020-08-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04639050",
"publication_url": "https://clinicaltrials.gov/study/NCT04639050",
"title": "A Phase Ib/IIa, Randomized, Double Blind, Placebo-Controlled, Multiple Ascending Dose, Parallel-Group Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Patients With Prodromal or Mild to Moderate Alzheimer's Disease",
"has_exemption": false,
"start_date": "2021-03-15",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05422222",
"publication_url": "https://clinicaltrials.gov/study/NCT05422222",
"title": "A Phase 3 Study Evaluating the Pharmacokinetics, Safety, and Tolerability of VX-121/Tezacaftor/Deutivacaftor Triple Combination Therapy in Cystic Fibrosis Subjects 1 Through 11 Years of Age",
"has_exemption": false,
"start_date": "2022-06-21",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05633615",
"publication_url": "https://clinicaltrials.gov/study/NCT05633615",
"title": "A Randomized Phase II Trial of Consolidation Therapy Following CD19 CAR T-Cell Treatment for Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Grade IIIB Follicular Lymphoma",
"has_exemption": false,
"start_date": "2023-06-12",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06118892",
"publication_url": "https://clinicaltrials.gov/study/NCT06118892",
"title": "Post-Market Evaluation of the MISHA® Knee System for Symptom Relief in Subjects With Medial Knee Osteoarthritis",
"has_exemption": false,
"start_date": "2023-11-03",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Moximed",
"sponsor_slug": "moximed",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06384573",
"publication_url": "https://clinicaltrials.gov/study/NCT06384573",
"title": "The Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Amyloid Removal Trial (ART): A Phase IIIb/IV Open-Label Study of Lecanemab to Evaluate Prevention and Progression of Dominantly Inherited Alzheimer's Disease",
"has_exemption": false,
"start_date": "2024-06-10",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06904313",
"publication_url": "https://clinicaltrials.gov/study/NCT06904313",
"title": "Evaluation of Ultralow Dose PET Imaging for Detecting PSMA Expression",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Akiva Mintz",
"sponsor_slug": "akiva-mintz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06956391",
"publication_url": "https://clinicaltrials.gov/study/NCT06956391",
"title": "Evaluation of Ultralow Dose PET Imaging for Detecting 18F-FDG Uptake",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Akiva Mintz",
"sponsor_slug": "akiva-mintz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07012993",
"publication_url": "https://clinicaltrials.gov/study/NCT07012993",
"title": "Evaluation of Ultralow Dose PET Imaging for Detecting Amyloid Tracer Uptake",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Akiva Mintz",
"sponsor_slug": "akiva-mintz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07038343",
"publication_url": "https://clinicaltrials.gov/study/NCT07038343",
"title": "A Phase 1/2, First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2025-06-04",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Avenzo Therapeutics, Inc.",
"sponsor_slug": "avenzo-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06464926",
"publication_url": "https://clinicaltrials.gov/study/NCT06464926",
"title": "A Prospective Randomized Controlled Trial of Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System",
"has_exemption": false,
"start_date": "2025-06-23",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Enterra Medical, Inc.",
"sponsor_slug": "enterra-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06474273",
"publication_url": "https://clinicaltrials.gov/study/NCT06474273",
"title": "A Multicenter Randomized Controlled Trial to Treat Acute t Cell Mediated Rejection in Kidney and Kidney-pancreas Transplant Recipients",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Sydney",
"sponsor_slug": "university-of-sydney",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06953089",
"publication_url": "https://clinicaltrials.gov/study/NCT06953089",
"title": "A Phase II, Multicenter, Open-Label Trial of DB-1311 in Combination With BNT327 or DB-1305 in Participants With Advanced/Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2025-07-18",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "DualityBio Inc.",
"sponsor_slug": "dualitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284563",
"publication_url": "https://clinicaltrials.gov/study/NCT07284563",
"title": "Evaluation of Ultralow Dose PET Imaging for Detecting 18F-NaF Uptake",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Akiva Mintz",
"sponsor_slug": "akiva-mintz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07212686",
"publication_url": "https://clinicaltrials.gov/study/NCT07212686",
"title": "An Open-Label, Single-Center Study of Synthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory Hypotension Despite Receiving Fluid Therapy and Vasoactive Therapy",
"has_exemption": false,
"start_date": "2025-09-09",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Todd Sweberg",
"sponsor_slug": "todd-sweberg",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06520098",
"publication_url": "https://clinicaltrials.gov/study/NCT06520098",
"title": "Benefit of Venetoclax Addition (\"Benefit VA\") in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07067463",
"publication_url": "https://clinicaltrials.gov/study/NCT07067463",
"title": "A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Primary Progressive Multiple Sclerosis",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Zenas BioPharma (USA), LLC",
"sponsor_slug": "zenas-biopharma-usa-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223814",
"publication_url": "https://clinicaltrials.gov/study/NCT07223814",
"title": "Bleximenib or Placebo in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for the Treatment of Patients With Newly Diagnosed KMT2A-rearranged or NPM1-mutant Acute Myeloid Leukemia Eligible for Intensive Chemotherapy: a Double-blind Phase 3 Study",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stichting Hemato-Oncologie voor Volwassenen Nederland",
"sponsor_slug": "stichting-hemato-oncologie-voor-volwassenen-nederland",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284576",
"publication_url": "https://clinicaltrials.gov/study/NCT07284576",
"title": "Evaluation of 0.25mCi PET Imaging for Detecting Cardiac Perfusion",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Akiva Mintz",
"sponsor_slug": "akiva-mintz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699966",
"publication_url": "https://clinicaltrials.gov/study/NCT06699966",
"title": "Stony Brook Medicine Anti-Inflammatory Trial",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stony Brook University",
"sponsor_slug": "stony-brook-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214649",
"publication_url": "https://clinicaltrials.gov/study/NCT07214649",
"title": "A Prospective Study Using Patient-Derived Extrahepatic Cholangiocyte Organoids for Refractory Bile Leaks",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS",
"sponsor_slug": "fondazione-policlinico-universitario-agostino-gemelli-irccs",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07084441",
"publication_url": "https://clinicaltrials.gov/study/NCT07084441",
"title": "Comparison of Outcomes of Management of Bowel Obstruction",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07436793",
"publication_url": "https://clinicaltrials.gov/study/NCT07436793",
"title": "Evaluating Promising Progestins in Endometrial Cancer Through a Rotating Umbrella Surgical Window Trial - The PRO-WINDOW TRIAL for Endometrial Cancer",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "New Mexico Cancer Research Alliance",
"sponsor_slug": "new-mexico-cancer-research-alliance",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07135596",
"publication_url": "https://clinicaltrials.gov/study/NCT07135596",
"title": "Research on the Effectiveness and Safety of Treatment With OviTex® PRS - a Breast Reconstruction Evaluation",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Tela Bio Inc",
"sponsor_slug": "tela-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07299019",
"publication_url": "https://clinicaltrials.gov/study/NCT07299019",
"title": "A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Non-active Secondary Progressive Multiple Sclerosis",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Zenas BioPharma (USA), LLC",
"sponsor_slug": "zenas-biopharma-usa-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07428499",
"publication_url": "https://clinicaltrials.gov/study/NCT07428499",
"title": "A Phase 3 Extension Study of siRNA Targeting of Prekallikrein With ADX-324 in Participants With Hereditary Angioedema",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ADARx Pharmaceuticals, Inc.",
"sponsor_slug": "adarx-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07415044",
"publication_url": "https://clinicaltrials.gov/study/NCT07415044",
"title": "A Randomized, Multicenter, Double-Blind, Placebo-Controlled Development Program to Evaluate the Efficacy and Safety of LY4268989 (MORF-057) for the Treatment of Adults With Moderately to Severely Active Ulcerative Colitis (EMERALD-3)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07398508",
"publication_url": "https://clinicaltrials.gov/study/NCT07398508",
"title": "Phase I/II Study of NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease: Double-blind Placebo-controlled Randomized Crossover Clinical Trial.",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stephen G. Kaler",
"sponsor_slug": "stephen-g-kaler",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07032701",
"publication_url": "https://clinicaltrials.gov/study/NCT07032701",
"title": "Assessing the Impact of a Disposable Negative Pressure Wound Therapy Device on Surgical Wounds of the Lower Extremities Following Mohs Micrographic Surgery",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07167940",
"publication_url": "https://clinicaltrials.gov/study/NCT07167940",
"title": "RAPID5: Rapid Acceleration Process for Intensive Treatment of PTSD in 5 Days",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07265830",
"publication_url": "https://clinicaltrials.gov/study/NCT07265830",
"title": "The Building Adaptive School-based Interventions for Caries Study (BASICS): A Phase III Sequential, Multiple-Assignment, Randomized Trial of Minimally Invasive Therapies to Reduce Treatment Nonresponse",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07210606",
"publication_url": "https://clinicaltrials.gov/study/NCT07210606",
"title": "Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06628778",
"publication_url": "https://clinicaltrials.gov/study/NCT06628778",
"title": "Collaborative Risk-stratified Investigation in Teen Inpatients With Critical Illness: Anticoagulation With LMWH in Kids for ThromboProphylaxis (CRITICAL-Kids-TP)",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins All Children's Hospital",
"sponsor_slug": "johns-hopkins-all-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288463",
"publication_url": "https://clinicaltrials.gov/study/NCT07288463",
"title": "Hearing Loss and Genetic Risks for Dementia",
"has_exemption": false,
"start_date": "2027-07-01",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Southern California",
"sponsor_slug": "university-of-southern-california",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04814082",
"publication_url": "https://clinicaltrials.gov/study/NCT04814082",
"title": "Prospective Functional, Gait, and Outcome Comparison Study of Medial Pivot",
"has_exemption": false,
"start_date": "2021-02-01",
"completion_date": "2030-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "LifeBridge Health",
"sponsor_slug": "lifebridge-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05564377",
"publication_url": "https://clinicaltrials.gov/study/NCT05564377",
"title": "Molecular Analysis for Combination Therapy Choice (ComboMATCH)",
"has_exemption": false,
"start_date": "2023-04-07",
"completion_date": "2030-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07121595",
"publication_url": "https://clinicaltrials.gov/study/NCT07121595",
"title": "PRECEDENT: Pilot Phase II Study of Personalized Radiation to the Contralateral Neck Directed by Sentinel Node Evaluation in Lateralized Oral Cavity Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-07-17",
"completion_date": "2030-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07456033",
"publication_url": "https://clinicaltrials.gov/study/NCT07456033",
"title": "The MODIFY Study: A Phase 3b/4 Randomized, Double-blind, Placebo-controlled, Multi-centre Study Evaluating the Impact of Early Intervention With Depemokimab on Exacerbation Rate, Clinical Remission, Lung Function Decline, and Safety in Adults and Adolescents With at Risk Type 2 Asthma, Conducted up to 156 Weeks",
"has_exemption": false,
"start_date": "2026-03-06",
"completion_date": "2030-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07418398",
"publication_url": "https://clinicaltrials.gov/study/NCT07418398",
"title": "Exoskeletal-assisted Walking Combined With Transcutaneous Spinal Cord Stimulation: Effect on Imaging and Serum Biomarkers of Skeletal Muscle Mass and Bone Strength",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2030-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07464028",
"publication_url": "https://clinicaltrials.gov/study/NCT07464028",
"title": "Assessing Target Engagement for Terazosin in Parkinson's Disease (TZPD2)",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2030-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Nandakumar Narayanan",
"sponsor_slug": "nandakumar-narayanan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04715646",
"publication_url": "https://clinicaltrials.gov/study/NCT04715646",
"title": "Open-Label, Single-Arm, Multicenter Study to Evaluate Long-Term Safety and Tolerability of Brivaracetam Used as Adjunctive Treatment in Pediatric Study Participants With Epilepsy",
"has_exemption": false,
"start_date": "2021-03-11",
"completion_date": "2030-07-08",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04684602",
"publication_url": "https://clinicaltrials.gov/study/NCT04684602",
"title": "Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions",
"has_exemption": false,
"start_date": "2020-07-09",
"completion_date": "2030-07-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Thomas Advanced Medical LLC",
"sponsor_slug": "thomas-advanced-medical-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07215585",
"publication_url": "https://clinicaltrials.gov/study/NCT07215585",
"title": "A Phase III, Multicentre, Open-Label, Randomised Study Evaluating the Efficacy and Safety of R-mini-CHOP x2 Followed by AZD0486 Versus R-mini-CHOP x6 in Elderly or Unfit Participants With Newly Diagnosed Large B-cell Lymphoma (SOUNDTRACK-D2)",
"has_exemption": false,
"start_date": "2025-11-11",
"completion_date": "2030-07-09",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227311",
"publication_url": "https://clinicaltrials.gov/study/NCT07227311",
"title": "A Phase 2, Multicenter, Open Label, Non-randomized Study to Evaluate the Efficacy and Safety of Extended Dosing of Belantamab Mafodotin in Different Combinations With Standard of Care Regimens in Participants With Relapsed-refractory Multiple Myeloma (DREAMM-15)",
"has_exemption": false,
"start_date": "2026-01-14",
"completion_date": "2030-07-10",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07146906",
"publication_url": "https://clinicaltrials.gov/study/NCT07146906",
"title": "An Open-label, Multicenter Study to Assess the Effect of Zigakibart Treatment on Histologic, Circulating, and Excreted Markers of Kidney Disease and Dysfunction in Adult Patients With IgA Nephropathy.",
"has_exemption": false,
"start_date": "2026-02-20",
"completion_date": "2030-07-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07470879",
"publication_url": "https://clinicaltrials.gov/study/NCT07470879",
"title": "A Phase 2 Open-Label, Single Arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Etrasimod in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-07-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07089901",
"publication_url": "https://clinicaltrials.gov/study/NCT07089901",
"title": "Project DEDUCE: Digital Envirotyping to Develop Understanding of Cigarette Smoking and the Environment",
"has_exemption": false,
"start_date": "2026-04-06",
"completion_date": "2030-07-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06054230",
"publication_url": "https://clinicaltrials.gov/study/NCT06054230",
"title": "Genomic Sequencing for Evaluation of Fetal Structural Anomalies",
"has_exemption": false,
"start_date": "2023-09-18",
"completion_date": "2030-07-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06678737",
"publication_url": "https://clinicaltrials.gov/study/NCT06678737",
"title": "CBIT+TMS R33 Phase",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2030-07-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07002216",
"publication_url": "https://clinicaltrials.gov/study/NCT07002216",
"title": "A Phase 2 Trial of Abbreviated Brentuximab Vedotin, Etoposide, Cyclophosphamide, Adriamycin, Dacarbazine, and Dexamethasone (BrECADD) Therapy in Stage 2 B-IV Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2030-07-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220720",
"publication_url": "https://clinicaltrials.gov/study/NCT07220720",
"title": "Inclusion of POSLUMA® ((18)F-rhPSMA-7.3) PET-CT Imaging Improves Diagnostic Accuracy of Clinically-Significant Prostate Cancer Diagnosis in Men With PIRADS 2 and 3 Lesions on MRI",
"has_exemption": false,
"start_date": "2025-11-04",
"completion_date": "2030-07-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06711887",
"publication_url": "https://clinicaltrials.gov/study/NCT06711887",
"title": "An Open-label Extension Study to Assess the Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Adult Participants With Lupus Nephritis Who Have Completed Study Treatment in the CVAY736K12301 Core Study (SIRIUS-LN Extension)",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2030-07-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02543983",
"publication_url": "https://clinicaltrials.gov/study/NCT02543983",
"title": "The Neurobiology of Suicide",
"has_exemption": false,
"start_date": "2015-12-01",
"completion_date": "2030-07-21",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Mental Health (NIMH)",
"sponsor_slug": "national-institute-of-mental-health-nimh",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07286266",
"publication_url": "https://clinicaltrials.gov/study/NCT07286266",
"title": "A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer",
"has_exemption": false,
"start_date": "2026-06-24",
"completion_date": "2030-07-22",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06022939",
"publication_url": "https://clinicaltrials.gov/study/NCT06022939",
"title": "A Phase III, Randomized Study of Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone (Dara-VCD) Induction Followed by Autologous Stem Cell Transplant or Dara-VCD Consolidation and Daratumumab Maintenance in Patients With Newly Diagnosed AL Amyloidosis",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2030-07-29",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03961945",
"publication_url": "https://clinicaltrials.gov/study/NCT03961945",
"title": "Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma",
"has_exemption": false,
"start_date": "2021-07-01",
"completion_date": "2030-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06561386",
"publication_url": "https://clinicaltrials.gov/study/NCT06561386",
"title": "A Phase 3, Randomized, Open-label Study of Nivolumab + Relatlimab Fixed-dose Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy as First-line Treatment for Participants With Non-squamous (NSQ), Stage IV or Recurrent Non-small Cell Lung Cancer and With Tumor Cell PD-L1 Expression ≥ 1%",
"has_exemption": false,
"start_date": "2024-10-07",
"completion_date": "2030-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06731413",
"publication_url": "https://clinicaltrials.gov/study/NCT06731413",
"title": "Phase 2 Study to Evaluate Reduced Dose Chemotherapy in Combination With Anti-PD-1 Therapy as First Line Treatment in Vulnerable or Older Adults (Vulnerable or Age ≥70) With Advanced PD-L1 TPS <50% Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2030-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06969755",
"publication_url": "https://clinicaltrials.gov/study/NCT06969755",
"title": "Biomarkers to Enhance Early Schizophrenia Treatment",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2030-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwell Health",
"sponsor_slug": "northwell-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07040566",
"publication_url": "https://clinicaltrials.gov/study/NCT07040566",
"title": "Investigating Efficacious E-Cigarette Interventions and Cessation Effects on Cancer-Related Biomarkers: A Randomized Trial of Varenicline in Adults",
"has_exemption": false,
"start_date": "2025-10-14",
"completion_date": "2030-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04373785",
"publication_url": "https://clinicaltrials.gov/study/NCT04373785",
"title": "A Multi-Center Pilot/Phase I and Phase II Clinical Trial of NG101m Adjuvant Therapy in Newly Diagnosed Glioblastoma Patients",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2030-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NeuGATE Theranostics",
"sponsor_slug": "neugate-theranostics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06716866",
"publication_url": "https://clinicaltrials.gov/study/NCT06716866",
"title": "Temporally Interfering Electric Field Stimulation in the Treatment of Epilepsy - Effect of Temporal Interference on Biomarkers of Epilepsy",
"has_exemption": false,
"start_date": "2019-01-16",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04188535",
"publication_url": "https://clinicaltrials.gov/study/NCT04188535",
"title": "RELAY: Repeated Magnetic Resonance Imaging Examinations to Analyze and Assess Your Cancer: A Prospective Study on the Use of Serial Magnetic Resonance Imaging in the Assessment of Changes During Treatment With Radiation Therapy",
"has_exemption": false,
"start_date": "2020-01-15",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04318717",
"publication_url": "https://clinicaltrials.gov/study/NCT04318717",
"title": "Adjuvant Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma",
"has_exemption": true,
"start_date": "2020-05-29",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04743141",
"publication_url": "https://clinicaltrials.gov/study/NCT04743141",
"title": "Phase 3, Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of Rimegepant for the Acute Treatment of Migraine (With or Without Aura) in Children and Adolescents ≥ 6 to < 18 Years of Age",
"has_exemption": false,
"start_date": "2021-04-28",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05145127",
"publication_url": "https://clinicaltrials.gov/study/NCT05145127",
"title": "AN OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF MARSTACIMAB PROPHYLAXIS IN SEVERE (COAGULATION FACTOR ACTIVITY <1%) HEMOPHILIA A PARTICIPANTS WITH OR WITHOUT INHIBITORS OR MODERATELY SEVERE TO SEVERE HEMOPHILIA B PARTICIPANTS (COAGULATION FACTOR ACTIVITY ≤2%) WITH OR WITHOUT INHIBITORS",
"has_exemption": false,
"start_date": "2021-11-17",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05469893",
"publication_url": "https://clinicaltrials.gov/study/NCT05469893",
"title": "Immuno-PRISM (PRecision Intervention Smoldering Myeloma): A Randomized Phase II Platform Study of Select Immunotherapies for High-Risk Smoldering Myeloma",
"has_exemption": false,
"start_date": "2022-08-10",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Irene Ghobrial, MD",
"sponsor_slug": "irene-ghobrial-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05131919",
"publication_url": "https://clinicaltrials.gov/study/NCT05131919",
"title": "Pembrolizumab for Locally Advanced, Irresectable, Non-metastatic dMMR Colorectal Cancers. The PUMA Study",
"has_exemption": false,
"start_date": "2022-12-22",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The Netherlands Cancer Institute",
"sponsor_slug": "the-netherlands-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05768139",
"publication_url": "https://clinicaltrials.gov/study/NCT05768139",
"title": "First-in-Human Study of STX-478, a Mutant-Selective PI3Kα Inhibitor as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2023-04-17",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06072131",
"publication_url": "https://clinicaltrials.gov/study/NCT06072131",
"title": "A Phase 3, Randomized, Open-Label Study Comparing the Efficacy and Safety of the Combination of Beleodaq-CHOP or Folotyn-COP to the CHOP Regimen Alone in Newly Diagnosed Patients With Peripheral T-Cell Lymphoma",
"has_exemption": false,
"start_date": "2023-10-04",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Acrotech Biopharma Inc.",
"sponsor_slug": "acrotech-biopharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05821855",
"publication_url": "https://clinicaltrials.gov/study/NCT05821855",
"title": "A Postmarketing Study Evaluating the Effectiveness and Safety of the XEN45 Glaucoma Treatment System in Subjects With Open-Angle Glaucoma in China",
"has_exemption": false,
"start_date": "2023-12-08",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06461897",
"publication_url": "https://clinicaltrials.gov/study/NCT06461897",
"title": "A Phase 3, Open-label, Efficacy-Assessor-Blinded Study, Comparing the Safety and Efficacy of Upadacitinib to Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis",
"has_exemption": false,
"start_date": "2024-08-19",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06577025",
"publication_url": "https://clinicaltrials.gov/study/NCT06577025",
"title": "A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of Different Sequences of Ciltacabtagene Autoleucel (Cilta-cel), Talquetamab SC in Combination With Daratumumab SC (Tal-D) and Teclistamab SC in Combination With Daratumumab SC (Tec-D) Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) in Participants With Standard-risk Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-08-20",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07007273",
"publication_url": "https://clinicaltrials.gov/study/NCT07007273",
"title": "Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma",
"has_exemption": false,
"start_date": "2025-06-20",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06992440",
"publication_url": "https://clinicaltrials.gov/study/NCT06992440",
"title": "Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension",
"has_exemption": false,
"start_date": "2025-06-26",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gustavo A Heresi, MD, MS",
"sponsor_slug": "gustavo-a-heresi-md-ms",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06950385",
"publication_url": "https://clinicaltrials.gov/study/NCT06950385",
"title": "A Phase 3, Multi-Site, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of eRapa to Improve Clinical Outcomes in Patients With Familial Adenomatous Polyposis",
"has_exemption": false,
"start_date": "2025-07-18",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rapamycin Holdings Inc.",
"sponsor_slug": "rapamycin-holdings-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07276035",
"publication_url": "https://clinicaltrials.gov/study/NCT07276035",
"title": "TMS Neuromodulation of Brain-to-Stomach Circuits in Chronic Nausea",
"has_exemption": false,
"start_date": "2026-01-28",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "David Levinthal",
"sponsor_slug": "david-levinthal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07101666",
"publication_url": "https://clinicaltrials.gov/study/NCT07101666",
"title": "Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06915233",
"publication_url": "https://clinicaltrials.gov/study/NCT06915233",
"title": "A Prospective, Open-label, Randomized, Concurrent Active-controlled, Longitudinal, Multicenter, Phase 3 Clinical Study of the Safety and Efficacy of MACI in Patients With Symptomatic Chondral or Osteochondral Lesions of the Talus (MASCOT)",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vericel Corporation",
"sponsor_slug": "vericel-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227584",
"publication_url": "https://clinicaltrials.gov/study/NCT07227584",
"title": "Treatment of Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in Adolescents and Young Adults (AYAs)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07225543",
"publication_url": "https://clinicaltrials.gov/study/NCT07225543",
"title": "Scavenging IsoLGs in Autoimmune Disease: a Proof-of-concept Clinical Study",
"has_exemption": false,
"start_date": "2026-05-15",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07211802",
"publication_url": "https://clinicaltrials.gov/study/NCT07211802",
"title": "Utilizing Continuous Ketone Monitors to Enable Safe Use of SGLT Inhibitors in Patients With Type 1 Diabetes",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07176546",
"publication_url": "https://clinicaltrials.gov/study/NCT07176546",
"title": "TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Robert Spiera, MD",
"sponsor_slug": "robert-spiera-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07261241",
"publication_url": "https://clinicaltrials.gov/study/NCT07261241",
"title": "NANT 2021-02: A Randomized Phase 2 Study of 131I-MIBG With Vorinostat VS. 131I-MIBG With Dinutuximab vs. 131I-MIBG With Dinutuximab and Vorinostat for Relapsed or Refractory Neuroblastoma",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "New Approaches to Neuroblastoma Therapy Consortium",
"sponsor_slug": "new-approaches-to-neuroblastoma-therapy-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07408583",
"publication_url": "https://clinicaltrials.gov/study/NCT07408583",
"title": "A Phase I/II, Non-Randomized Study of the Safety and Efficacy of In Utero Hematopoietic Stem Cell Transplantation for the Treatment of Fanconi Anemia in Affected Fetuses",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Agnieszka Czechowicz",
"sponsor_slug": "agnieszka-czechowicz",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}